Mount Sinai CEO Administration Appointments
Hi, friends and colleagues,
I’m writing to update you on some administrative changes happening at the Health System. Some are related to roles and responsibilities and others to how we make decisions and communicate. These changes are a small step toward operationalizing the shared vision—One Mount Sinai, for our patients, for our people, and for our world—that I outlined in my previous Carr Talk.
It is my pleasure to announce that Beth Yagoda, who has been the administrative lead for the Emergency Department, will assume the role of Chief Administrative Officer for the Health System. In this capacity, Ms. Yagoda will be directly responsible for oversight of the system’s administrative structure and processes.
Jeff Silberstein, who has served as the Chief Administrative Officer for the Health System since 2003, will focus full time on his Icahn School of Medicine at Mount Sinai roles as Chief Operating Officer and Dean for Operations. In this role, reporting to our Dean, Dennis S. Charney, MD, he will direct all corporate services for faculty and school staff, and will support the administrative operations of the clinical and basic science departments. Mr. Silberstein and Ms. Yagoda have been working together for months already and I have every confidence that they will increase coordination and alignment across the Health System and School as we become One Mount Sinai.
Emma Palmer, whom many of you know as the head of our Government Affairs office, will become my Chief of Staff. Ms. Palmer has been a critical strategic partner over the last few months, and this broadened role will allow her to drive interdisciplinary projects and implement strategic priorities both internal and external to the organization.
As we do this work, an important goal for me is to ensure that we are collaborative, transparent, and accountable to our staff and our patients. I will regularly convene an Executive Leadership Team that brings together leaders from across the Health System. I will also regularly convene clinical and research leadership forums to ensure open communication across portfolios and to focus our efforts as we continue to grow and align our enterprise.
We have unlimited potential and lots of important work ahead of us. This is an exciting time for Mount Sinai and I hope you will join me in congratulating Ms. Yagoda, Mr. Silberstein, and Ms. Palmer on their new roles.
Brendan G. Carr r, MD, MA, MS, is the Chief Executive Officer of the Mount Sinai Health System.
